RB1 gene mutations are a distinct predictive factor in Merkel cell carcinoma

Area of Science:

• Oncology
• Genetics
• Dermatology

Background:

• Merkel cell carcinoma (MCC) is a rare, aggressive skin cancer.
• MCC is often associated with the polyomavirus (MCPyV) and cytokeratin 20 (CK20).
• The origins and prognostic factors of MCC require further investigation.

Purpose of the Study:

• To investigate the developmental origins of MCC.
• To identify prognostic clinicopathologic factors in MCC.
• To explore the association between RB1 gene alterations and MCC metastasis.

Main Methods:

• Analysis of CK20 and MCPyV expression in MCC specimens.
• RB1 gene sequencing of formalin-fixed paraffin-embedded (FFPE) specimens.
• Immunohistochemistry to confirm RB1 alterations and metastasis.

Main Results:

• CK20 and MCPyV expression did not significantly impact overall survival.
• All cases with RB1 mutations (8/8) showed regional lymph node and/or distant metastases.
• RB1 mutation-negative cases had a significantly lower metastasis rate (62% vs. 100%, P = 0.033).
• RB1 alterations were statistically associated with metastasis (P = 0.007).

Conclusions:

• RB1 gene alterations are significantly associated with metastasis in Merkel cell carcinoma.
• RB1 mutation status can serve as a potential biomarker for predicting aggressive clinical behavior in MCC.
• Further research into RB1's role may improve MCC patient management and outcomes.